Parallax Volatility Advisers
NVO

Parallax Volatility Advisers’s Novo Nordisk NVO Stock Holding History

Parallax Volatility Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,936
Closed -$513K – 1657
2026
Q1 		$471K Sell
11,936
-33,490
-74% -$1.59M ﹤0.01% 1071
2025
Q4 		$2.31M Buy
45,426
+29,709
+189% +$1.52M ﹤0.01% 903
2025
Q3 		$872K Sell
15,717
-9,354
-37% -$548K ﹤0.01% 1142
2025
Q2 		$1.73M Sell
25,071
-46,740
-65% -$3.18M ﹤0.01% 931
2025
Q1 		$4.99M Sell
71,811
-61,276
-46% -$5.06M 0.01% 620
2024
Q4 		$11.4M Buy
133,087
+31,477
+31% +$3.4M 0.02% 525
2024
Q3 		$12.1M Buy
101,610
+63,434
+166% +$8.46M 0.02% 476
2024
Q2 		$5.45M Buy
38,176
+30,390
+390% +$4.03M 0.01% 694
2024
Q1 		$1,000K Buy
+7,786
New +$927K ﹤0.01% 1237
2023
Q3 		– Sell
-1,838
Closed -$149K – 2507
2023
Q2 		$149K Buy
+1,838
New +$150K ﹤0.01% 1939
2022
Q4 		– Sell
-12,214
Closed -$608K – 3142
2022
Q3 		$608K Buy
12,214
+7,694
+170% +$412K ﹤0.01% 1921
2022
Q2 		$252K Buy
+4,520
New +$251K ﹤0.01% 2137
2020
Q3 		– Sell
-612
Closed -$20K – 3123
2020
Q2 		$20K Buy
+612
New +$19.5K ﹤0.01% 2576
2019
Q3 		– Sell
-2
Closed – – 3093
2019
Q2 		$0 Buy
+2
New +$49 ﹤0.01% 3354
2019
Q1 		– Sell
-40,864
Closed -$941K – 3618
2018
Q4 		$941K Sell
40,864
-17,184
-30% -$382K ﹤0.01% 1339
2018
Q3 		$1.37M Buy
+58,048
New +$1.42M ﹤0.01% 1162
2018
Q2 		– Sell
-200
Closed -$5K – 2911
2018
Q1 		$5K Buy
+200
New +$5.25K ﹤0.01% 1941

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Parallax Volatility Advisers's NVO Position: Q2 2026 in Review

Parallax Volatility Advisers sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 11,936 shares — an estimated $513K sold.

Parallax Volatility Advisers first reported a position in NVO in Q1 2018 and held it in 17 quarters. The position peaked at $12.1M in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Parallax Volatility Advisers reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,936 Novo Nordisk shares in Q2 2026, an estimated $513K.
  • Parallax Volatility Advisers first reported a position in Novo Nordisk in Q1 2018 and held it in 17 quarters.
  • Parallax Volatility Advisers's Novo Nordisk position peaked at $12.1M in Q3 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.